These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15051739)

  • 1. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
    Cox CD; Tsikouris JP
    J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-induced nephropathy: a review.
    Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
    Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
    Asher I; Hammerman A; Sthoeger Z
    Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology and prevention of contrast-induced acute renal failure].
    Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G
    G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
    Duong MH; MacKenzie TA; Malenka DJ
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we prevent acute kidney injury?
    Venkataraman R
    Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast nephropathy: review focusing on prevention.
    Maeder M; Klein M; Fehr T; Rickli H
    J Am Coll Cardiol; 2004 Nov; 44(9):1763-71. PubMed ID: 15519005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
    Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of contrast-induced nephropathy: a critical review.
    Van Praet JT; De Vriese AS
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):336-47. PubMed ID: 17565276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-induced nephropathy.
    Pucelikova T; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to reduce the risk of contrast-induced nephropathy.
    Stacul F; Adam A; Becker CR; Davidson C; Lameire N; McCullough PA; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):59K-77K. PubMed ID: 16949381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to prevent contrast nephropathy.
    Oudemans-van Straaten HM
    Minerva Cardioangiol; 2005 Oct; 53(5):445-63. PubMed ID: 16179886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pharmacological protocols to prevent or reduce contrast media nephropathy.
    Briguori C; Airoldi F; Morici N; Colombo A
    Minerva Cardioangiol; 2005 Feb; 53(1):49-58. PubMed ID: 15788979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine in the prevention of contrast-induced nephropathy.
    Fishbane S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast agent--associated nephrotoxicity.
    Briguori C; Tavano D; Colombo A
    Prog Cardiovasc Dis; 2003; 45(6):493-503. PubMed ID: 12800130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.